Literature DB >> 17966393

Novel signaling pathways and therapeutic targets in osteoclasts.

Hiroshi Takayanagi1.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 17966393     DOI: 10.1007/978-0-387-72009-8_12

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  1 in total

1.  Zoledronic acid inhibits RANK expression and migration of osteoclast precursors during osteoclastogenesis.

Authors:  Keiichiro Kimachi; Hiroshi Kajiya; Shuji Nakayama; Tetsuro Ikebe; Koji Okabe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-01-12       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.